April 2020: Capital increase with public offering

April 2020: Capital increase with public offering

0 Flares 0 Flares ×
Capital volumeCHF 27.1 million
Number of shares1,000,000 new bearer shares with nominal value CHF 0.10 each
Issue priceCHF 27.10 each share
Subscription deadlineBy Thursday, April 30, 2020 with enclosed subscription form
Minimum subscription500 shares / CHF 13,550
AllocationDecision of the Board of Directors in consideration of subscription rights
DepositBy Thursday, April 30, 2020 to the escrow account of InnoMedica Holding AG at UBS Switzerland AG (IBAN: CH03 0023 5235 2621 75D7 L)
ContactMs Andrea Zurkirchen, phone: +41 (0)44 383 88 22,
e-mail: andrea.zurkirchen@innomedica.ch
Public offerView publication at SHAB website
Investor eventsDue to the current corona situation, investor events are held online. Pre-register here.
Please find below the relevant investor documents (including subscription form). Information on InnoMedica and the projects TaliCoVax-19 (vaccination), Talidox (oncology) and Talineuren (neurology) can be found in the business documentation.

Investor Documentation

Download Subscription Form

Download Prospectus April 2020

Download Annual Report 2019

Download Business Documentation 2020


Download last year’s documents

0 Flares Twitter 0 Facebook 0 Google+ 0 LinkedIn 0 0 Flares ×